Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
02/21/2025 | CALL | $20.00 | 4,467 | +937 | +26.54% |
01/17/2025 | CALL | $20.00 | 2,692 | +454 | +20.29% |
05/16/2025 | CALL | $17.50 | 698 | +175 | +33.46% |
05/16/2025 | CALL | $20.00 | 624 | +73 | +13.25% |
02/21/2025 | CALL | $15.00 | 149 | +19 | +14.62% |
05/16/2025 | PUT | $25.00 | 13 | +4 | +44.44% |
12/19/2025 | PUT | $30.00 | 0 | 0 | |
12/19/2025 | PUT | $35.00 | 0 | 0 | |
01/17/2025 | CALL | $12.50 | 14 | -3 | -17.65% |
02/21/2025 | CALL | $17.50 | 589 | -3 | -0.51% |
01/17/2025 | CALL | $17.50 | 105 | -18 | -14.63% |
01/17/2025 | CALL | $15.00 | 68 | -19 | -21.84% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Blackrock Funds-Health Sciences Opportunity Portfolio | 0.36% | 1.27M | 24.86M |
Fidelity Strategic Advisors Small-Mid Cap Fund | 0.22% | 778.24k | 15.25M |
Northern Lights Fd Tr II-Invenomic Fd | 0.20% | 711.4k | 13.94M |
BlackRock Health Sciences Trust II | 0.15% | 523.55k | 10.26M |
Franklin Mutual Series Fund-Mutual Quest Fund | 0.13% | 467.51k | 9.16M |
First Trust U.S. Equity Opportunities ETF | 0.06% | 213.89k | 4.19M |
JNL Series Trust-JNL/Multi Manager Small Cap Value Fund | 0.05% | 164.34k | 3.22M |
Professionally Managed Portf-Hodges Small Cap Fund | 0.04% | 150k | 2.94M |
AMG Managers River Road Small Mid Cap Value Fund | 0.04% | 127.14k | 2.49M |
JP Morgan ETF Tr-BetaBuilders Canada ETF | 0.04% | 125.53k | 2.46M |
Ophthalmic Drugs Global Market Report 2025: Innovations in Retinal Disorders, Glaucoma Drive Global Ophthalmic Medicines Surge
01/13 05:46 am
GlobeNewswire Inc.
Read moreImplantable Drug Delivery Devices Business Research Report 2023-2024 & 2030 - Rising Focus on Biocompatible and Biodegradable Implantable Devices
01/08 12:57 pm
GlobeNewswire Inc.
Read moreOphthalmic Lasers Market Forecast Report to 2029: Key Trends Include Growing Popularity of Femtosecond Lasers in Ophthalmic Surgery and Growing Preference for Minimally Invasive Ophthalmic Procedures
01/06 10:44 am
GlobeNewswire Inc.
Read moreOcular Prosthesis Market Trends, Challenges and Opportunities to 2030: A Projected $2.3 Billion Landscape
12/24 06:57 am
GlobeNewswire Inc.
Read moreAesthetic Ophthalmology Devices Business Analysis Report 2024-2030 Featuring 40+ Key Players Including Abbott, Bausch & Lomb, Alcon, Allergan, Carl Zeiss, Haag Streit, Meditec, Topcon, Zeimer
12/23 11:59 am
GlobeNewswire Inc.
Read moreOphthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030
12/16 12:52 pm
GlobeNewswire Inc.
Read moreDeal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags
10/21 02:46 pm
Benzinga
Read moreWhy Bausch + Lomb Stock Soared by Over 7% on Monday
10/14 06:40 pm
The Motley Fool
Read moreBausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
09/22 05:34 pm
Benzinga
Read moreHelsinn Group appoints Riccardo Carbucicchio to the Board of Directors
09/19 08:00 am
GlobeNewswire Inc.
Read moreWhy Bausch + Lomb Rallied Today
09/16 03:31 pm
The Motley Fool
Read moreContact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
09/16 01:22 pm
Benzinga
Read moreMilestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
09/04 08:00 am
GlobeNewswire Inc.
Read moreBausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say
07/31 09:30 am
Zacks Investment Research
Read moreNicox announces attendance at upcoming conferences - GlobeNewswire
07/19 01:31 am
GlobeNewswire Inc.
Read moreNicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director - GlobeNewswire
07/16 01:31 am
GlobeNewswire Inc.
Read moreIndia Vision Care Market Predicted to Witness Substantial Growth Through 2030 - GlobeNewswire
07/03 10:50 am
GlobeNewswire Inc.
Read moreGlobal Colored Contact Lenses Market Size To Worth USD 9.82 Billion By 2033 | CAGR Of 7.67% - GlobeNewswire
07/03 10:02 am
GlobeNewswire Inc.
Read moreWhy Is Clearside Biomedical Stock Gaining Today?
06/25 12:54 pm
Benzinga
Read moreAmerican Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
05/06 07:56 am
Benzinga
Read moreEarnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
04/25 10:01 am
Zacks Investment Research
Read moreAnalysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
04/24 10:01 am
Zacks Investment Research
Read moreBLCO vs. AVTR: Which Stock Is the Better Value Option?
04/08 11:40 am
Zacks Investment Research
Read moreAll You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy
03/25 12:00 pm
Zacks Investment Research
Read moreBLCO or AVTR: Which Is the Better Value Stock Right Now?
03/21 11:40 am
Zacks Investment Research
Read moreBLCO or AVTR: Which Is the Better Value Stock Right Now?
03/21 10:41 am
Zacks Investment Research
Read moreSurging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock
03/20 12:20 pm
Zacks Investment Research
Read moreTracking Carl Icahn's 13F Report - Q4 2023 Update
03/04 03:15 am
Seeking Alpha
Read moreBarclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know
02/26 01:00 pm
Benzinga
Read moreBausch & Lomb’s stock soars 9% after earnings beat
02/21 12:18 pm
MarketWatch
Read moreToll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
02/21 11:47 am
Benzinga
Read moreCompared to Estimates, Bausch + Lomb (BLCO) Q4 Earnings: A Look at Key Metrics
02/21 10:30 am
Zacks Investment Research
Read moreWall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
02/21 07:51 am
Benzinga
Read moreSeeking Clues to Bausch + Lomb (BLCO) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
02/15 10:15 am
Zacks Investment Research
Read moreWill Bausch + Lomb (BLCO) Beat Estimates Again in Its Next Earnings Report?
02/14 01:10 pm
Zacks Investment Research
Read moreBausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Should You Buy?
02/14 11:00 am
Zacks Investment Research
Read moreEarnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
02/09 03:24 pm
Benzinga
Read moreThe Latest Analyst Ratings for Bausch & Lomb
12/04 09:00 am
Benzinga
Read moreAlcon stock falls as third-quarter sales miss estimates
11/15 09:49 am
MarketWatch
Read moreStocks Edge Higher Ahead Of Federal Reserve Decision, Bonds Surge After Softer Treasury Refunding Plan: What's Driving Markets Wednesday?
11/01 01:23 pm
Benzinga
Read moreBausch + Lomb (BLCO) Reports Q3 Earnings: What Key Metrics Have to Say
11/01 09:30 am
Zacks Investment Research
Read moreApple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
10/30 03:40 am
Benzinga
Read moreAnalysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for
10/26 10:02 am
Zacks Investment Research
Read moreBausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
10/25 10:02 am
Zacks Investment Research
Read moreAldeyra (ALDX) Plummets on Dry Eye Disease Drug's Setback
10/17 10:13 am
Zacks Investment Research
Read moreNovartis (NVS) Spins off Sandoz, Reiterates Annual Outlook
10/04 11:47 am
Zacks Investment Research
Read more6 Analysts Have This to Say About Bausch & Lomb
10/03 12:00 pm
Benzinga
Read moreNovartis (NVS) Announces Positive Data on Kidney Disease Drug
10/03 11:50 am
Zacks Investment Research
Read moreIs the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock?
09/19 08:32 am
Zacks Investment Research
Read more